{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T10:03:35Z","timestamp":1786269815306,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with diabetes mellitus have an increased risk of incident atrial fibrillation (AF). The effect of accumulated hypertension burden is a less well-known modifiable risk factor. We explored the relationship between accumulated hypertension burden and incident AF in these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We evaluated data for 526,384 patients with diabetes who underwent three consecutive health examinations, between 2009 and 2012, from the Korean National Health Insurance Service. Hypertension burden was calculated by assigning points to each stage of hypertension in each health examination: 1 for stage 1 hypertension (systolic blood pressure [SBP] 130\u2013139\u00a0mmHg; diastolic blood pressure [DBP] 80\u201389\u00a0mmHg); 2 for stage 2 (SBP 140\u2013159\u00a0mmHg and DBP 90\u201399\u00a0mmHg); and 3 for stage 3 (SBP\u2009\u2265\u2009160\u00a0mmHg or DBP\u2009\u2265\u2009100\u00a0mmHg). Patients were categorized into 10 hypertensive burden groups (0\u20139). Groups 1\u20139 were then clustered into 1\u20133, 4\u20136, and 7\u20139.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During a mean follow-up duration of 6.7\u2009\u00b1\u20091.7\u00a0years, AF was newly diagnosed in 18,561 (3.5%) patients. Compared to patients with hypertension burden 0, those with burden 1 to 9 showed a progressively increasing risk of incident AF: 6%, 11%, 16%, 24%, 28%, 41%, 46%, 57%, and 67% respectively. Clusters 1\u20133, 4\u20136, and 7\u20139 showed increased risks by 10%, 26%, and 45%, respectively, when compared to a hypertension burden of 0.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Accumulated hypertension burden was associated with an increased risk of incident AF in patients with diabetes. Strict BP control should be emphasized for these patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-01736-4","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T17:02:53Z","timestamp":1674147773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study"],"prefix":"10.1186","volume":"22","author":[{"given":"JungMin","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So\u2011Ryoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eue\u2011Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuiJin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MinJu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jeong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soonil","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung\u2011Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seil","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"issue":"2","key":"1736_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88\u201398.","journal-title":"Nat Rev Endocrinol"},{"key":"1736_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157: 107843.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9859","key":"1736_CR3","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095\u2013128.","journal-title":"Lancet"},{"issue":"1","key":"1736_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol. 2018;17(1):83.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"1736_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.4065\/76.7.707","volume":"76","author":"HS Abu-Lebdeh","year":"2001","unstructured":"Abu-Lebdeh HS, Hodge DO, Nguyen TT. Predictors of macrovascular disease in patients with type 2 diabetes mellitus. Mayo Clin Proc. 2001;76(7):707\u201312.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"1736_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1524-6175.2005.04379.x","volume":"7","author":"SI McFarlane","year":"2005","unstructured":"McFarlane SI, Sica DA, Sowers JR. Stroke in patients with diabetes and hypertension. J Clin Hypertens (Greenwich). 2005;7(5):286\u201392.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"5","key":"1736_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1462-8902.2004.00358.x","volume":"6","author":"CJ Ostgren","year":"2004","unstructured":"Ostgren CJ, Merlo J, R\u00e5stam L, Lindblad U. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab. 2004;6(5):367\u201374.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1736_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12933-019-0983-1","volume":"19","author":"S Seyed Ahmadi","year":"2020","unstructured":"Seyed Ahmadi S, Svensson AM, Pivodic A, Rosengren A, Lind M. Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study. Cardiovasc Diabetol. 2020;19(1):9.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"1736_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13633","volume":"51","author":"R Abellana","year":"2021","unstructured":"Abellana R, Gonzalez-Loyola F, Verdu-Rotellar JM, Bustamante A, Pal\u00e0 E, Clua-Espuny JL, Montaner J, Pedrote A, Del Val-Garcia JL, Ribas Segui D, et al. Predictive model for atrial fibrillation in hypertensive diabetic patients. Eur J Clin Invest. 2021;51(12): e13633.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"1736_CR10","first-page":"799","volume":"46","author":"S Cheol Seong","year":"2016","unstructured":"Cheol Seong S, Kim Y-Y, Khang Y-H, Heon Park J, Kang H-J, Lee H, Do C-H, Song J-S, Hyon Bang J, Ha S, et al. Data resource profile: the national health information database of the national health insurance service in South Korea. Int J Epidemiol. 2016;46(3):799\u2013800.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1736_CR11","first-page":"363","volume":"53","author":"W-C Lee","year":"2010","unstructured":"Lee W-C, Lee S-Y. National Health Screening Program of Korea. jkma. 2010;53(5):363\u201370.","journal-title":"jkma"},{"issue":"2","key":"1736_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.119.13708","volume":"75","author":"S-R Lee","year":"2020","unstructured":"Lee S-R, Choi Y-J, Choi E-K, Han K-D, Lee E, Cha M-J, Oh S, Lip GYH. Blood pressure variability and incidence of New-Onset Atrial Fibrillation. Hypertension. 2020;75(2):309\u201315.","journal-title":"Hypertension"},{"issue":"6","key":"1736_CR13","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206\u201352.","journal-title":"Hypertension"},{"issue":"19","key":"1736_CR14","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127\u2013248.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1736_CR15","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334\u201357.","journal-title":"Hypertension"},{"issue":"1","key":"1736_CR16","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1038\/s41598-021-84307-5","volume":"11","author":"CS Park","year":"2021","unstructured":"Park CS, Han K-D, Choi E-K, Kim DH, Lee H-J, Lee S-R, Oh S. Lifestyle is associated with atrial fibrillation development in patients with type 2 diabetes mellitus. Sci Rep. 2021;11(1):4676.","journal-title":"Sci Rep"},{"issue":"9","key":"1736_CR17","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4070\/kcj.2020.0171","volume":"50","author":"EK Choi","year":"2020","unstructured":"Choi EK. Cardiovascular research using the Korean National Health Information Database. Korean Circ J. 2020;50(9):754\u201372.","journal-title":"Korean Circ J"},{"issue":"10","key":"1736_CR18","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, et al. Heart Disease and Stroke Statistics-2019 Update: a report from the American Heart Association. Circulation. 2019;139(10):e56\u2013528.","journal-title":"Circulation"},{"issue":"4","key":"1736_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1540-8167.2007.01037.x","volume":"19","author":"T Kato","year":"2008","unstructured":"Kato T, Yamashita T, Sekiguchi A, Tsuneda T, Sagara K, Takamura M, Kaneko S, Aizawa T, Fu LT. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat. J Cardiovasc Electrophysiol. 2008;19(4):415\u201320.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"1736_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1536\/ihj.50.627","volume":"50","author":"H Otake","year":"2009","unstructured":"Otake H, Suzuki H, Honda T, Maruyama Y. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J. 2009;50(5):627\u201341.","journal-title":"Int Heart J"},{"issue":"9","key":"1736_CR21","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/eurheartj\/ehp055","volume":"30","author":"X Du","year":"2009","unstructured":"Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S, Hamet P, et al. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J. 2009;30(9):1128\u201335.","journal-title":"Eur Heart J"},{"issue":"11","key":"1736_CR22","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jacc.2017.07.755","volume":"70","author":"JB Echouffo-Tcheugui","year":"2017","unstructured":"Echouffo-Tcheugui JB, Shrader P, Thomas L, Gersh BJ, Kowey PR, Mahaffey KW, Singer DE, Hylek EM, Go AS, Peterson ED, et al. Care patterns and outcomes in atrial fibrillation patients with and without diabetes: ORBIT-AF Registry. J Am Coll Cardiol. 2017;70(11):1325\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1736_CR23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s11606-010-1340-y","volume":"25","author":"S Dublin","year":"2010","unstructured":"Dublin S, Glazer NL, Smith NL, Psaty BM, Lumley T, Wiggins KL, Page RL, Heckbert SR. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med. 2010;25(8):853\u20138.","journal-title":"J Gen Intern Med"},{"issue":"12","key":"1736_CR24","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.amjcard.2019.09.009","volume":"124","author":"S Yang","year":"2019","unstructured":"Yang S, Choi EK, Han KD, Kwon S, Lee SY, Park J, Choi YJ, Lee HJ, Moon I, Lee E, et al. Risk of Atrial Fibrillation in Relation to the Time Course of Type 2 Diabetes Mellitus and Fasting Blood Glucose. Am J Cardiol. 2019;124(12):1881\u20138.","journal-title":"Am J Cardiol"},{"issue":"6","key":"1736_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","volume":"136","author":"DH Lau","year":"2017","unstructured":"Lau DH, Nattel S, Kalman JM, Sanders P. Modifiable risk factors and atrial fibrillation. Circulation. 2017;136(6):583\u201396.","journal-title":"Circulation"},{"issue":"3","key":"1736_CR26","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/HYPERTENSIONAHA.120.16659","volume":"77","author":"SR Lee","year":"2021","unstructured":"Lee SR, Park CS, Choi EK, Ahn HJ, Han KD, Oh S, Lip GYH. Hypertension burden and the risk of new-onset atrial fibrillation: a nationwide population-based study. Hypertension. 2021;77(3):919\u201328.","journal-title":"Hypertension"},{"issue":"2","key":"1736_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.pcd.2020.11.001","volume":"15","author":"T Sabuncu","year":"2021","unstructured":"Sabuncu T, Sonmez A, Eren MA, Sahin I, \u00c7orap\u00e7io\u011flu D, \u00dc\u00e7ler R, Akin \u015e, Haymana C, Demirci \u0130, Atmaca A, et al. Characteristics of patients with hypertension in a population with type2 diabetes mellitus. Results from the Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Hypertension Study). Prim Care Diabetes. 2021;15(2):332\u20139.","journal-title":"Prim Care Diabetes"},{"issue":"9","key":"1736_CR28","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.hrthm.2010.05.010","volume":"7","author":"DH Lau","year":"2010","unstructured":"Lau DH, Mackenzie L, Kelly DJ, Psaltis PJ, Brooks AG, Worthington M, Rajendram A, Kelly DR, Zhang Y, Kuklik P, et al. Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model. Heart Rhythm. 2010;7(9):1282\u201390.","journal-title":"Heart Rhythm"},{"issue":"16","key":"1736_CR29","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJM199904223401601","volume":"340","author":"A Mosterd","year":"1999","unstructured":"Mosterd A, D\u2019Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, Levy D. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med. 1999;340(16):1221\u20137.","journal-title":"N Engl J Med"},{"issue":"7","key":"1736_CR30","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1097\/HJH.0b013e328338c20e","volume":"28","author":"PM Okin","year":"2010","unstructured":"Okin PM, Gerdts E, Wachtell K, Oikarinen L, Nieminen MS, Dahl\u00f6f B, Devereux RB. Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation. J Hypertens. 2010;28(7):1534\u201340.","journal-title":"J Hypertens"},{"issue":"5","key":"1736_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1161\/CIRCULATIONAHA.117.028441","volume":"136","author":"EZ Soliman","year":"2017","unstructured":"Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, et al. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: SPRINT (Systolic Blood Pressure Intervention Trial). Circulation. 2017;136(5):440\u201350.","journal-title":"Circulation"},{"issue":"12","key":"1736_CR32","first-page":"789","volume":"10","author":"JM Dernellis","year":"1996","unstructured":"Dernellis JM, Vyssoulis GP, Zacharoulis AA, Toutouzas PK. Effects of antihypertensive therapy on left atrial function. J Hum Hypertens. 1996;10(12):789\u201394.","journal-title":"J Hum Hypertens"},{"issue":"Suppl 1","key":"1736_CR33","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.2337\/dc21-S009","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S111\u201324.","journal-title":"Diabetes Care"},{"issue":"11","key":"1736_CR34","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1007\/s00125-021-05551-y","volume":"64","author":"G Fauchier","year":"2021","unstructured":"Fauchier G, Bisson A, Bodin A, Herbert J, Angoulvant D, Ducluzeau PH, Lip GYH, Fauchier L. Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus. Diabetologia. 2021;64(11):2602\u20135.","journal-title":"Diabetologia"},{"issue":"3","key":"1736_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/s-0040-1716408","volume":"121","author":"TS Potpara","year":"2021","unstructured":"Potpara TS, Lip GYH, Blomstrom-Lundqvist C, Boriani G, Van Gelder IC, Heidbuchel H, Hindricks G, Camm AJ. The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): a novel approach to in-depth characterization (rather than classification) of atrial fibrillation. Thromb Haemost. 2021;121(3):270\u20138.","journal-title":"Thromb Haemost"},{"issue":"11","key":"1736_CR36","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","volume":"14","author":"GYH Lip","year":"2017","unstructured":"Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol. 2017;14(11):627\u20138.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"1736_CR37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1055\/a-1515-9630","volume":"122","author":"GF Romiti","year":"2022","unstructured":"Romiti GF, Pastori D, Rivera-Caravaca JM, Ding WY, Gue YX, Menichelli D, Gumprecht J, Kozie\u0142 M, Yang PS, Guo Y, et al. Adherence to the \u201cAtrial fibrillation better care\u201d pathway in patients with Atrial Fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients. Thromb Haemost. 2022;122(3):406\u201314.","journal-title":"Thromb Haemost"},{"issue":"1","key":"1736_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0041-1739411","volume":"122","author":"TF Chao","year":"2022","unstructured":"Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, Guo Y, Sriratanasathavorn C, Oh S, Okumura K, et al. 2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: executive summary. Thromb Haemost. 2022;122(1):20\u201347.","journal-title":"Thromb Haemost"},{"issue":"34","key":"1736_CR39","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1093\/eurheartj\/ehx316","volume":"38","author":"SS Lee","year":"2017","unstructured":"Lee SS, Ae Kong K, Kim D, Lim Y-M, Yang P-S, Yi J-E, Kim M, Kwon K, Bum Pyun W, Joung B, et al. Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea. Eur Heart J. 2017;38(34):2599\u2013607.","journal-title":"Eur Heart J"},{"issue":"3","key":"1736_CR40","first-page":"799","volume":"46","author":"S Cheol Seong","year":"2017","unstructured":"Cheol Seong S, Kim YY, Khang YH, Heon Park J, Kang HJ, Lee H, Do CH, Song JS, Hyon Bang J, Ha S, et al. Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46(3):799\u2013800.","journal-title":"Int J Epidemiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01736-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T17:03:29Z","timestamp":1674147809000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01736-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01736-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]},"assertion":[{"value":"17 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EKC: Research grants or speaking fees from Abbott, Bayer, BMS\/Pfizer, Biosense Webster, Chong Kun Dang, Daewoong Pharmaceutical Co., Daiichi-Sankyo, DeepQure, Dreamtech Co., Ltd., Jeil Pharmaceutical Co. Ltd, Medtronic, Samjinpharm, Seers Technology, and Skylabs. GYHL: Consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim, and Daiichi-Sankyo. No fees were received personally by any author. The remaining authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}